Related content

Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor

By Jong K. P. de   Hoedemakers R. M. J.   Fidler V.   Bijzet J.   Limburg P. C.   Peeters P. M. J. G.   Vries E. G. E. de   Slooff M. J. H.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1141-1148

Informa Healthcare

Access to resources Recommend Favorite

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation

By Gouin-Thibault I.   Arkam R.   Nassiri S.   de la Tourette A.   Conard J.   Horellou M.H.   Elalamy I.   Samama M.M.  

Thrombosis Research, Vol. 107, Iss. 1, 2002-07 ,pp. : 7-11

Elsevier

Access to resources Recommend Favorite

Incidence of the Factor V Leiden-mutation, Coagulation Inhibitor Deficiency, and Elevated Antiphospholipid-antibodies in Patients with Preeclampsia or HELLP-Syndrome

By von Tempelhoff G.-F.   Heilmann L.   Spanuth E.   Kunzmann E.   Hommel G.  

Thrombosis Research, Vol. 100, Iss. 4, 2000-11 ,pp. : 363-365

Elsevier

Access to resources Recommend Favorite

Plasma Level of Triglyceride-rich Lipoprotein Remnants Is Closely Associated with the Activation of Coagulation Factor VII in Patients with Myocardial Infarction

By Saigo M.   Abe S.   Ogawa M.   Biro S.   Minagoe S.   Maruyama I.   Toda H.   Kiyonaga K.   Atsuchi Y.   Tahara M.   Mawatari K.   Tei C.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite